157 related articles for article (PubMed ID: 21315180)
1. Advances in the computational development of DNA methyltransferase inhibitors.
Medina-Franco JL; Caulfield T
Drug Discov Today; 2011 May; 16(9-10):418-25. PubMed ID: 21315180
[TBL] [Abstract][Full Text] [Related]
2. Molecular modeling and molecular dynamics studies of hydralazine with human DNA methyltransferase 1.
Singh N; Dueñas-González A; Lyko F; Medina-Franco JL
ChemMedChem; 2009 May; 4(5):792-9. PubMed ID: 19322801
[TBL] [Abstract][Full Text] [Related]
3. Novel and selective DNA methyltransferase inhibitors: Docking-based virtual screening and experimental evaluation.
Kuck D; Singh N; Lyko F; Medina-Franco JL
Bioorg Med Chem; 2010 Jan; 18(2):822-9. PubMed ID: 20006515
[TBL] [Abstract][Full Text] [Related]
4. Discovery and development of DNA methyltransferase inhibitors using in silico approaches.
Medina-Franco JL; Méndez-Lucio O; Dueñas-González A; Yoo J
Drug Discov Today; 2015 May; 20(5):569-77. PubMed ID: 25526932
[TBL] [Abstract][Full Text] [Related]
5. C5-DNA methyltransferase inhibitors: from screening to effects on zebrafish embryo development.
Ceccaldi A; Rajavelu A; Champion C; Rampon C; Jurkowska R; Jankevicius G; Sénamaud-Beaufort C; Ponger L; Gagey N; Ali HD; Tost J; Vriz S; Ros S; Dauzonne D; Jeltsch A; Guianvarc'h D; Arimondo PB
Chembiochem; 2011 Jun; 12(9):1337-45. PubMed ID: 21633996
[TBL] [Abstract][Full Text] [Related]
6. Rapid synthesis of new DNMT inhibitors derivatives of procainamide.
Halby L; Champion C; Sénamaud-Beaufort C; Ajjan S; Drujon T; Rajavelu A; Ceccaldi A; Jurkowska R; Lequin O; Nelson WG; Guy A; Jeltsch A; Guianvarc'h D; Ferroud C; Arimondo PB
Chembiochem; 2012 Jan; 13(1):157-65. PubMed ID: 22170584
[TBL] [Abstract][Full Text] [Related]
7. Computational fishing of new DNA methyltransferase inhibitors from natural products.
Maldonado-Rojas W; Olivero-Verbel J; Marrero-Ponce Y
J Mol Graph Model; 2015 Jul; 60():43-54. PubMed ID: 26099696
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids.
Lee WJ; Shim JY; Zhu BT
Mol Pharmacol; 2005 Oct; 68(4):1018-30. PubMed ID: 16037419
[TBL] [Abstract][Full Text] [Related]
9. From natural products to drugs for epimutation computer-aided drug design.
Chikan NA; Bhavaniprasad V; Anbarasu K; Shabir N; Patel TN
Appl Biochem Biotechnol; 2013 May; 170(1):164-75. PubMed ID: 23483409
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel bacterial M.SssI DNA methyltransferase inhibitors.
Hupkes M; Azevedo R; Jansen H; van Zoelen EJ; Dechering KJ
J Biomol Screen; 2013 Mar; 18(3):348-55. PubMed ID: 23103529
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of inhibition of DNA (cytosine C5)-methyltransferases by oligodeoxyribonucleotides containing 5,6-dihydro-5-azacytosine.
Sheikhnejad G; Brank A; Christman JK; Goddard A; Alvarez E; Ford H; Marquez VE; Marasco CJ; Sufrin JR; O'gara M; Cheng X
J Mol Biol; 1999 Feb; 285(5):2021-34. PubMed ID: 9925782
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of DNA methyltransferases: insights from computational studies.
Yoo J; Medina-Franco JL
Curr Med Chem; 2012; 19(21):3475-87. PubMed ID: 22709005
[TBL] [Abstract][Full Text] [Related]
13. DNA methyltransferases in hematologic malignancies.
Li KK; Luo LF; Shen Y; Xu J; Chen Z; Chen SJ
Semin Hematol; 2013 Jan; 50(1):48-60. PubMed ID: 23507483
[TBL] [Abstract][Full Text] [Related]
14. Developing new chemical tools for DNA methyltransferase 1 (DNMT 1): a small-molecule activity-based probe and novel tetrazole-containing inhibitors.
Zhu B; Ge J; Yao SQ
Bioorg Med Chem; 2015 Jun; 23(12):2917-27. PubMed ID: 25801160
[TBL] [Abstract][Full Text] [Related]
15. Molecular modeling and virtual screening of DNA methyltransferase inhibitors.
Medina-Franco JL; Yoo J
Curr Pharm Des; 2013; 19(12):2138-47. PubMed ID: 23016844
[TBL] [Abstract][Full Text] [Related]
16. Activity landscape of DNA methyltransferase inhibitors bridges chemoinformatics with epigenetic drug discovery.
Naveja JJ; Medina-Franco JL
Expert Opin Drug Discov; 2015 Oct; 10(10):1059-70. PubMed ID: 26289576
[TBL] [Abstract][Full Text] [Related]
17. SAR around (l)-S-adenosyl-l-homocysteine, an inhibitor of human DNA methyltransferase (DNMT) enzymes.
Saavedra OM; Isakovic L; Llewellyn DB; Zhan L; Bernstein N; Claridge S; Raeppel F; Vaisburg A; Elowe N; Petschner AJ; Rahil J; Beaulieu N; MacLeod AR; Delorme D; Besterman JM; Wahhab A
Bioorg Med Chem Lett; 2009 May; 19(10):2747-51. PubMed ID: 19362833
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation inhibitors in cancer: recent and future approaches.
Gros C; Fahy J; Halby L; Dufau I; Erdmann A; Gregoire JM; Ausseil F; Vispé S; Arimondo PB
Biochimie; 2012 Nov; 94(11):2280-96. PubMed ID: 22967704
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic cancer therapy: Proof of concept and remaining challenges.
Mund C; Lyko F
Bioessays; 2010 Nov; 32(11):949-57. PubMed ID: 21154865
[TBL] [Abstract][Full Text] [Related]
20. Epigenetics and cancer treatment.
Kristensen LS; Nielsen HM; Hansen LL
Eur J Pharmacol; 2009 Dec; 625(1-3):131-42. PubMed ID: 19836388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
